| Question 20 | Physiological control of systemic vascular resistance (SVR). |
| Question 5 | Beta-blockers - labetalol vs esmolol |
| Question 17 | |
| Question 13 | |
| Question 11 | Amiodarone: side effects |
| Question 9 | Classification of β-blockers; also metoprolol vs esmolol |
| Question 3 |
| Question 20 | |
| Question 19 | |
| Question 5 | |
| Question 1 |
| Question 20 | Pharmacology of sodium nitroprusside |
| Question 18 | All about afterload |
| Question 15 | |
| Question 1 | Normal action potential vs. the action potential in a pacemaker cell |
| Question 19 | |
| Question 12 | |
| Question 7 | |
| Question 2 | Nitrate vasodilators: Pharmacology of GTN |
| Question 18 | |
| Question 16 | |
| Question 14 | Beta-blockers: compare metoprolol and esmolol |
| Question 6 | |
| Question 2 |
| Question 14 | |
| Question 13 | Classification of shock, and circulatory responses to shock |
| Question 8 | |
| Question 4 | Functional anatomy of the kidney and regulation of renal blood flow |
| Question 2 | Arterial line pressure transducer setup and waveform interpretation |
| Question 18 | Factors affecting left ventricular function: afterload, contractility and preload |
| Question 16 | Starling forces in the systemic circulation |
| Question 6 | |
| Question 2 |
| Question 12 | The cardiac cycle: events during diastole |
| Question 11 | |
| Question 7 | Gastrointestinal blood supply: arteries and veins |
| Question 2 | Adrenaline vs. milrinone |
| Question 21 | |
| Question 19 | Cardiac reflexes: vasovagal syncope |
| Question 17 | |
| Question 15 | Adrenaline: an ideal inotrope? |
| Question 10 | |
| Question 8 | Calcium channel blockers: pharmacology of nimodipine |
| Question 23 | |
| Question 20 | Pharmacology of vasoactive drugs: vasopressin and its analogues |
| Question 19 | |
| Question 15 |
| Question 21 | Classification of antiarrhythmic agents and sotalol |
| Question 19 | Starling forces in the pulmonary circulation |
| Question 15 | |
| Question 13 | |
| Question 11 | |
| Question 7 | Myocardial oxygen supply and demand: LV vs RV |
| Question 2 | Nitrate vasodilators: GTN vs. nitroprusside |
| Question 13 | Afterload: what would happen if it suddenly increased? |
| Question 11 | Amiodarone: mainly the side effects |
| Question 9 |
| Question 23 | |
| Question 15 | |
| Question 3 | A comparison of hepatic and renal blood flow |
| Question 19 | |
| Question 12 | |
| Question 11 | Nitrate vasodilators: Pharmacology of sodium nitroprusside |
| Question 19 | |
| Question 16 | Function of baroreceptors and clinical relevance of the baroreflex |
| Question 13 | Amiodarone: pharmacology |
| Question 10 | |
| Question 1 |
| Question 19 | Cardiac output: definition, determinants and thermodilution measurement |
| Question 14 | |
| Question 12 | |
| Question 2 | Calcium channel blockers: pharmacology of verepamil |
| Question 24 | |
| Question 10 | Pharmacology of vasoactive agents: digoxin vs levosimendan |
| Question 2 |
| Question 22 | Pharmacology of vasoactive agents: Vasopressin and its analogues |
| Question 19 | |
| Question 18 | |
| Question 10 | Pharmacology of antihypertensives: carvedilol and spironolactone |
| Question 3 |
| Question 23 | |
| Question 18 | Adrenaline: an ideal inotrope? |
| Question 9 | Classification of antiarrhythmic agents and Class I agent pharmacology |
| Question 4 |
| Question 24 | |
| Question 17 | |
| Question 11 | A comparison of hepatic and renal blood flow |
| Question 9 | Physiological response to normal ageing: cardiovascular changes |
| Question 8 | Pharmacology of vasoactive drugs: adrenaline vs. levosimendan |
| Question 21 | Functional anatomy and physiology of renal medullary blood flow |
| Question 17 | Calcium channel blockers: compare verapamil and nimodipine |
| Question 16 | |
| Question 14 | Pharmacology of vasoactive agents: dobutamine vs. milrinone |
| Question 13 | Regulation of cardiac output via vascular function curves |
| Question 9 | |
| Question 6 | Humoral control of the circulation: the RAAS system |
| Question 5 |
| Question 21 | The cardiac cycle: events during diastole |
| Question 18 | Starling forces and the mechanism of oedema formation |
| Question 13 |
Relationship of the surface ECG to the events of the cardiac cycle |
| Question 12 | Measurement of cardiac output by the indicator dilution technique |
| Question 8 | Determinants of cardiac output: specifically, of the right ventricle |
| Question 7 |
| Question 24 | Classification of antihypertensive agents by mechanism |
| Question 23 | The Cardiac Cycle and normal processes of cardiac electrical activity |
| Question 22 | |
| Question 17 |
| Question 9(p.2) | |
| Question 4(p.2) | |
| Question 7 | |
| Question 1 |
| Question 6(p.2) | Humoral control of the circulation: specifically, angiotensin |
| Question 12 | Pharmacology of vasoactive agents: noradrenaline |
| Question 5 |
| Question 11 | |
| Question 7 | |
| Question 1 | Relationship of surface ECG to the cardiac cycle |
| Question 9(p.2) | The effects of ACE-inhibitors and ARBs on the management of CCF |
| Question 8(p.2) | Nitrate vasodilators: GTN vs. nitroprusside |
| Question 1(p.2) | |
| Question 12 | |
| Question 11 | |
| Question 5 | Amiodarone: pharmacology |
| Question 12(p.2) | |
| Question 7(p.2) | Conduction system and counter-arrhythmic mechanisms |
| Question 4(p.2) | |
| Question 3(p.2) | Nitrate vasodilators: GTN vs. nitroprusside |
| Question 12 | Classification of inotropes |
| Question 10 | |
| Question 5 |
| Question 7(p.2) | |
| Question 6(p.2) | |
| Question 8 | Function of baroreceptors and clinical relevance of the baroreflex |
| Question 1 |